Rakesh Sharma

Rakesh Sharma

Auto-generated profile, based on publicly available information

Rakesh Sharma

Institute of Bioinformatics, Bangalore, India

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2013 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
VNVishalakshi Nanjappa
Vishalakshi Nanjappa
JTJoji Kurian Thomas
Joji Kurian Thomas
AMArivusudar Marimuthu
Arivusudar Marimuthu
BMBabylakshmi Muthusamy
Babylakshmi Muthusamy
ARAneesha Radhakrishnan
Aneesha Radhakrishnan
TPT. S. Keshava Prasad
T. S. Keshava Prasad
Plasma Proteome Database (PPD; http://www.plasmaproteomedatabase.org/) was initially described in the year 2005 as a part of Human Proteome Organization’s (HUPO’s) pilot initiative on Human Plasma Proteome Project. Since then, improvements in proteomic technologies and increased throughput have led to identification of a large number of novel plasma proteins. To keep up with this increase in data, we have significantly enriched the proteomic information in PPD. This database currently contains information on 10 546 proteins detected in serum/plasma of which 3784 have been reported in two or more studies. The latest version of the database also incorporates mass spectrometry-derived data including experimentally verified proteotypic peptides used for multiple reaction monitoring assays. Other novel features include published plasma/serum concentrations for 1278 proteins along with a separate category of plasma-derived extracellular vesicle proteins. As plasma proteins have become a major thrust in the field of biomarkers, we have enabled a batch-based query designated Plasma Proteome Explorer, which will permit the users in screening a list of proteins or peptides against known plasma proteins to assess novelty of their data set. We believe that PPD will facilitate both clinical and basic research by serving as a comprehensive reference of plasma proteins in humans and accelerate biomarker discovery and translation efforts.

18 April 2011 in Journal of Proteome Research
Verified
Journal Article
Closed access
AMArivusudar Marimuthu
Arivusudar Marimuthu
RORobert. N. O’mEally
Robert. N. O’mEally
RCRaghothama Chaerkady
Raghothama Chaerkady
Yashwanth SubbannayyaYashwanth Subbannayya
Yashwanth Subbannayya
VNVishalakshi Nanjappa
Vishalakshi Nanjappa
APAkhilesh Pandey
Akhilesh Pandey

14 July 2014 in Clinical Proteomics
Verified
Journal Article
Open access
PDF file
KMKrishna R Murthy
Krishna R Murthy
RGRenu Goel
Renu Goel
Yashwanth SubbannayyaYashwanth Subbannayya
Yashwanth Subbannayya
HJHarrys Kishore Charles Jacob
Harrys Kishore Charles Jacob
PMPraveen R Murthy
Praveen R Murthy
APAkhilesh Pandey
Akhilesh Pandey
The vitreous humor is a transparent, gelatinous mass whose main constituent is water. It plays an important role in providing metabolic nutrient requirements of the lens, coordinating eye growth and providing support to the retina. It is in close proximity to the retina and reflects many of the changes occurring in this tissue. The biochemical changes occurring in the vitreous could provide a better understanding about the pathophysiological processes that occur in vitreoretinopathy. In this study, we investigated the proteome of normal human vitreous humor using high resolution Fourier transform mass spectrometry. The vitreous humor was subjected to multiple fractionation techniques followed by LC-MS/MS analysis. We identified 1,205 proteins, 682 of which have not been described previously in the vitreous humor. Most proteins were localized to the extracellular space (24%), cytoplasm (20%) or plasma membrane (14%). Classification based on molecular function showed that 27% had catalytic activity, 10% structural activity, 10% binding activity, 4% cell and 4% transporter activity. Categorization for biological processes showed 28% participate in metabolism, 20% in cell communication and 13% in cell growth. The data have been deposited to the ProteomeXchange with identifier PXD000957. This large catalog of vitreous proteins should facilitate biomedical research into pathological conditions of the eye including diabetic retinopathy, retinal detachment and cataract.

1 February 2015 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
AAAditi S. Ambekar
Aditi S. Ambekar
DKDhanashree S. Kelkar
Dhanashree S. Kelkar
SPSneha Maria Pinto
Sneha Maria Pinto
RSRakesh Sharma
Rakesh Sharma
IHIndira Hinduja
Indira Hinduja
SMSrabani Mukherjee
Srabani Mukherjee
Context: Polycystic ovary syndrome (PCOS), a major cause of anovulatory infertility, is characterized by arrested follicular growth. Altered protein levels in the follicular fluid surrounding the ovum may reflect the molecular defects of folliculogenesis in these women. Objective: To identify differentially regulated proteins in PCOS by comparing the follicular fluid protein repertoire of PCOS with healthy women. Methods: The follicular fluid samples were collected from PCOS and normo-ovulatory women undergoing in vitro fertilization. Follicular fluid proteins were subjected to digestion using trypsin, and resultant peptides were labeled with isobaric tags for relative and absolute quantification reagents and analyzed by liquid chromatography tandem mass spectrometry. Differential abundance of selected proteins was confirmed by ELISA. Results: A total of 770 proteins were identified, of which 186 showed differential abundance between controls and women with PCOS. Proteins involved in various processes of follicular development including amphiregulin; heparan sulfate proteoglycan 2; tumor necrosis factor, α-induced protein 6; plasminogen; and lymphatic vessel endothelial hyaluronan receptor 1 were found to be deregulated in PCOS. We also identified a number of new proteins from follicular fluid, whose function in the ovary is not yet clearly established. These include suprabasin; S100 calcium binding protein A7; and helicase with zinc finger 2, transcriptional coactivator. Conclusions: Proteins indispensable for follicular growth were found to be differentially expressed in follicular fluid of women with PCOS, which may in part explain the aberrant folliculogenesis observed in these women.

1 October 2018 in Cell Reports
Verified
Journal Article
Open access
LCLok Hei Chan
Lok Hei Chan
LZLei Zhou
Lei Zhou
KNKai Yu Ng
Kai Yu Ng
TWTin Wong
Tin Wong
TLTerence K. Lee
Terence K. Lee
SMStephanie KY Ma
Stephanie KY Ma
Arginine methylation is a post-translational modification that plays pivotal roles in signal transduction and gene transcription during cell fate determination. We found protein methyltransferase 6 (PRMT6) to be frequently downregulated in hepatocellular carcinoma (HCC) and its expression to negatively correlate with aggressive cancer features in HCC patients. Silencing of PRMT6 promoted the tumor-initiating, metastasis, and therapy resistance potential of HCC cell lines and patient-derived organoids. Consistently, loss of PRMT6 expression aggravated liver tumorigenesis in a chemical-induced HCC PRMT6 knockout (PRMT6-/-) mouse model. Integrated transcriptome and protein-protein interaction studies revealed an enrichment of genes implicated in RAS signaling and showed that PRMT6 interacted with CRAF on arginine 100, which decreased its RAS binding potential and altered its downstream MEK/ERK signaling. Our work describes a critical repressive function for PRMT6 in maintenance of HCC cells by regulating RAS binding and MEK/ERK signaling via methylation of CRAF on arginine 100.

31 July 2019 in Communications Biology
Verified
Journal Article
Open access
PDF file
RCRain R. Chen
Rain R. Chen
MYMingo Ming Ho YUNG
Mingo Ming Ho YUNG
YXYang Xuan
Yang Xuan
SZShijie Zhan
Shijie Zhan
LLLee Leanne Leung
Lee Leanne Leung
David ChanDavid Chan
David Chan
Ovarian cancer is an intra-abdominal tumor in which the presence of ascites facilitates metastatic dissemination, and associated with poor prognosis. However, the significance of metabolic alterations in ovarian cancer cells in the ascites microenvironment remains unclear. Here we show ovarian cancer cells exhibited increased aggressiveness in ascites microenvironment via reprogramming of lipid metabolism. High lipid metabolic activities are found in ovarian cancer cells when cultured in the ascites microenvironment, indicating a metabolic shift from aerobic glycolysis to β-oxidation and lipogenesis. The reduced AMP-activated protein kinase (AMPK) activity due to the feedback effect of high energy production led to the activation of its downstream signaling, which in turn, enhanced the cancer growth. The combined treatment of low toxic AMPK activators, the transforming growth factor beta-activated kinase 1 (TAK1) and fatty acid synthase (FASN) inhibitors synergistically impair oncogenic augmentation of ovarian cancer. Collectively, targeting lipid metabolism signaling axis impede ovarian cancer peritoneal metastases.